Stock Information
Ionis Pharmaceuticals Inc (IONS)
Ticker Symbol: IONS
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $9,600.10 mil
Piotroski score: 5
PE Ratio: N/A
EPS (TTM): -3.47
Revenue (TTM): $5.28 M
Dividend Yield: N/A
ROE: -110.92%
Latest News
-
Cathie Wood Makes $64 Million Bet on Two Stocks
Mon, Sep 28, 2026 7:11 PM
-
4 RNA Therapeutics Stocks Leading the Next Wave of Innovation
Mon, Sep 28, 2026 1:57 PM
-
Alnylam Pharmaceuticals: More Than Meets The Eye After CARDIO-TTRansform
Mon, Sep 28, 2026 12:04 PM
-
Ionis Pharmaceuticals (IONS) Stock Looks Pricey On Its 45% YTD Slide
Fri, Sep 25, 2026 12:18 AM
-
Failure of Novartis’ Pelacarsen Could Reshape the Lp(a) Race for CRISPR and Ionis
Thu, Sep 24, 2026 4:42 PM
-
HC Wainwright & Co. Reiterates Buy on Ionis Pharmaceuticals, Maintains $100 Price Target
Thu, Sep 24, 2026 6:59 AM
-
The Biggest Losers In Biotech — And It Had Nothing To Do With 'Compelling,' 'Best-In-Disease' Data
Wed, Sep 23, 2026 8:12 PM
-
Roche, Ionis RNA drug scores in kidney disease study
Wed, Sep 23, 2026 4:21 PM
-
Ionis Delivers Positive Late-Stage Results for Two Partnered Drugs
Wed, Sep 23, 2026 4:13 PM
-
Ionis and Roche Advance First RNA-Targeted Therapy for Autoimmune Kidney Disease
Wed, Sep 23, 2026 12:13 PM
Key Financials
Financial data not available
